Business · Companies · 1 hr ago

TDS Pharm seeks overseas patents for non-opioid pain patch

TDS Pharm seeks overseas patents for non-opioid pain patch

South Korean company TDS Pharm filed overseas patent applications for a non-opioid pain patch in the United States, Europe and Japan.

The patch is designed to deliver medicine through the skin and excludes opioid ingredients and skin penetration enhancers.

In January, the company registered a South Korean patent for a combined formula containing a non-steroidal anti-inflammatory drug, a local anesthetic and an antidepressant.

TDS Pharm says the patch aims to keep medicine levels steady and reduce skin side effects, while offering an alternative to opioid painkillers.

It is intended for pain ranging from muscle aches to chronic cancer, nerve-related and inflammatory pain.

The company plans to make and supply finished products itself from its plant in Osong, rather than transfer the product rights.

Patent approval and supply deals with global drug distributors are still ahead, so the company’s plans depend on securing those rights and agreements.

1 source

Related

What people are saying

TDS Pharm representativeCompany representative
After obtaining the patents, we plan to pursue supply contracts with global pharmaceutical distributors seeking next-generation combination patch formulations as existing patch patents expire.
via Maeil Business
We will make a leap forward as a high-value biotech company with foundational technology.
via Maeil Business